BridgeMD
New treatment option for IVF
Official title Trial to Evaluate the Clinical Utility of Non-invasive Endometrial Receptivity Test (Ora) in Patients With Implantation Failure
ClinicalTrials.gov ID: NCT06544837
What this study is testing
- What it's testing
- The adjustment of the timing of embryo transfer based on the endometrial receptivity profile and transferring embryo(s) of good quality with normal chromosomes (diagnosed by Preimplantation Genetic Testing for Aneuploidy, PGT-A) are the two main causes to improve the success of assisted reproduction treatments (ART). Previously, endometrial receptivity analysis was performed on women undergoing IVF treatment through an invasive endometrial tissue biopsy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 28 to 45, women only
You may be able to join if
- Experienced implantation failure with euploid or low-level mosaic (\< 30%) embryos in the past two years.
- Female age 28-45 years.
- Consent to undergo a simulated cycle for non-invasive optimal implantation window testing.
- Plan to undergo a frozen embryo transfer cycle.
- Have at least one euploid or low-level mosaic (\< 30%) frozen blastocyst.
You likely can't join if
- Presence of uterine cavity abnormalities that may affect implantation, such as polyps, fibroids ≧4 cm, or hydrosalpinx
- Presence of systemic diseases that may affect reproductive techniques (e.g., autoimmune diseases)
- Body mass index (BMI) over 30 kg/m²
The study team makes the final eligibility decision.
Where it's taking place
- Hanoi, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 28 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hanoi, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.